Skip to main content
SpringerLink
Log in

Treatment of Childhood Acute Nonlymphoblastic Leukemia — Final Results of the Austrian-Hungarian Study AML-IGCL-84

  • Conference paper
Acute Leukemias V

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 37))

  • 74 Accesses

Abstract

In the treatment of childhood acute nonlymphoblastic leukemia remission rates of 70 to 80 percent can be achieved by a variety of intensive induction chemotherapy regimens [1–5]. Anthracycline antibiotics are among the most effective agents for the treatment of ANLL. Therefore these drugs or related compounds are used in high doses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Creutzig U, Ritter J, Riehm H, Langermann HJ, Henze G, Kabisch H, Niethammer D, Jürgens H, Stollmann B, Lasson U, Kaufmann U, Löffler H, Schellong G (1985) Improved treatment results in childhood acute myelogenous leukemia. Blood 65: 298

    PubMed  CAS  Google Scholar 

  2. Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315–319

    PubMed  CAS  Google Scholar 

  3. Buckley JD, Chard RL, Baehner RL, Nesbit ME, Lampkin BC, Woods WG, Hammond GD (1989) Improvement in outcome for children with acute nonlymphocytic leukemia. A report from the Children’s Cancer Study Group. Cancer 63: 1457–1465

    Article  PubMed  CAS  Google Scholar 

  4. Amadori S, Ceci A, Comelli A, Madon E, Masera G, Nespoli L, Paolucci G, Zanesco L, Covelli A, Mandelli F (1987) Treatment of acute myelogenous leukemia in children: results of the Italian cooperative study AEIOP/LAM 8204. J Clin Oncol 5: 1356–1363

    PubMed  CAS  Google Scholar 

  5. Creutzig U, Ritter J, Schellong G (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 75: 1932–1940

    PubMed  CAS  Google Scholar 

  6. Warrell RP, Arlin ZA, Zempin SJ, Young CW (1982) Phase I-II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia. Cancer Treat Rep 66: 1619–1623

    PubMed  Google Scholar 

  7. Yamada K, Nakamura T, Tsurno T, et al. (1980) A phase II study of aclacinomycin A in acute leukemia in adults. Cancer Treat Rev 7: 177–182

    Article  PubMed  CAS  Google Scholar 

  8. Pedersen-Bjergaard J, Brincker H, Ellegard J, Drivsholm A, Freund L, Jensen KB, Jensen MK, Missen NI (1984) Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine.: a phase II trial. Cancer Treat Rep 68: 1233–1238

    PubMed  CAS  Google Scholar 

  9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukemias. French-American-British (FAB) cooperative groups. Br J Haematol 33: 451–458

    Article  PubMed  CAS  Google Scholar 

  10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). A report of the French-American-British cooperative group. Ann Intern Med 103: 460

    PubMed  CAS  Google Scholar 

  11. Rowe JM, Chang AY, Bennett JM (1988)Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia. Blood 71: 992–996

    PubMed  CAS  Google Scholar 

  12. Hansen OP, Pedersen-Bjergaard J, Ellegaard J, Brincker H, Boesen AM, Christensen BE, Drivsholm A, Hippe E, Jans H, Jensen KB, et al. (1991) Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark. Leukemia 5: 510–516

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Pediatrics, University of Innsbruck, Innsbruck, Austria

    F. M. Fink

  2. St. Anna Children’s Hospital, Vienna, Austria

    G. Mann, E. R. Panzer-Grümayer & H. Gadner

  3. Teaching Hospital Szombathely, Szombathely, Hungary

    P. Masát

  4. Semmelweis University Medical School Budapest, Budapest, Hungary

    D. Schuler

Authors
  1. F. M. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Masát
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. R. Panzer-Grümayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Kajtar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Kardos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ch. Urban
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Schuler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. Gadner
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

IGCI Pediatric Study Group

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, University of Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany

    W. Hiddemann  & W. Plunkett  & 

  2. Department of Internal Medicine, University of Münster, Albert-Schweitzer-Strasse 33, 48145, Münster, Germany

    T. Büchner

  3. Department of Pediatric Oncology, University of Münster, Albert-Schweitzer-Strasse 33, 48145, Münster, Germany

    J. Ritter

  4. Department of Internal Medicine, MD Anderson Cancer Center, 1515 Holcombe Blvd., 77030, Houston, TX, USA

    B. Wörmann M.D., Ph.D.  & M. J. Keating M.D., B.S.  & 

  5. Koordinierungsstelle, Deutsche Krebsgesellschaft e.V., Thea-Bähnisch-Weg 12, 30657, Hannover, Germany

    U. Creutzig

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fink, F.M. et al. (1996). Treatment of Childhood Acute Nonlymphoblastic Leukemia — Final Results of the Austrian-Hungarian Study AML-IGCL-84. In: Hiddemann, W., et al. Acute Leukemias V. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78907-6_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78907-6_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78909-0

  • Online ISBN: 978-3-642-78907-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation